Home Coronavirus COVID-19 AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant February 7, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Sheinbaum: US Destroyer in Gulf Waters ‘Not an Attack on Mexico’ Sheinbaum Announces 6 Immediate Measures to Address Mexico’s Missing Persons Crisis Mexican President Sheinbaum Maintaining ‘Cool Head’ toward the U.S.’ 25% Tariffs on Steel and Aluminum Rancho Izaguirre: Mexico’s Auschwitz? Mexican Peso Hits 4-Month High, Strengthens Below 20 to the US Dollar
